Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs

被引:96
作者
Cuniasse, P
Devel, L
Makaritis, A
Beau, F
Georgiadis, D
Matziari, A
Yiotakis, A
Dive, V [1 ]
机构
[1] CEA Saclay, Dept Ingn Etudes Prot, F-91191 Gif Sur Yvette, France
[2] Univ Athens, Organ Chem Lab, Dept Organ Chem, Athens 15771, Greece
关键词
MMPs; inhibitors; zinc protease; conformational variability; inhibitor selectivity;
D O I
10.1016/j.biochi.2004.09.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite a deep knowledge on the 3D-structure of several catalytic domains of MMPs, the development of highly specific synthetic active-site-directed inhibitors of MMPs, able to differentiate the different members of this protease family, remains a strong challenge. Due to the flexible nature of NIMP active-site, the development of specific NIMP inhibitors will need to combine sophisticated theoretical and experimental approaches to decipher in each MMP the specific structural and dynamic features that can be exploited to obtain the desired selectivity. (c) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:393 / 402
页数:10
相关论文
共 69 条
[21]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[22]   Inhibition of stromelysin-1 (MMP-3) by P-1'-biphenylylethyl carboxyalkyl dipeptides [J].
Esser, CK ;
Bugianesi, RL ;
Caldwell, CG ;
Chapman, KT ;
Durette, PL ;
Girotra, NN ;
Kopka, IE ;
Lanza, TJ ;
Levorse, DA ;
MacCoss, M ;
Owens, KA ;
Ponpipom, MM ;
Simeone, JP ;
Harrison, RK ;
Niedzwiecki, L ;
Becker, JW ;
Marcy, AI ;
Axel, MG ;
Christen, AJ ;
McDonnell, J ;
Moore, VL ;
Olszewski, JM ;
Saphos, C ;
Visco, DM ;
Shen, F ;
Colletti, A ;
Krieter, PA ;
Hagmann, WK .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :1026-1040
[23]   Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor [J].
Feng, YQ ;
Likos, JJ ;
Zhu, LM ;
Woodward, H ;
Munie, G ;
McDonald, JJ ;
Stevens, AM ;
Howard, CP ;
De Crescenzo, GA ;
Welsch, D ;
Shieh, HS ;
Stallings, WC .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2002, 1598 (1-2) :10-23
[24]   Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity [J].
Finzel, BC ;
Baldwin, ET ;
Bryant, GL ;
Hess, GF ;
Wilks, JW ;
Trepod, CM ;
Mott, JE ;
Marshall, VP ;
Petzold, GL ;
Poorman, RA ;
O'Sullivan, TJ ;
Schostarez, HJ ;
Mitchell, MA .
PROTEIN SCIENCE, 1998, 7 (10) :2118-2126
[25]   Crystal structure of the Stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state [J].
Gall, AL ;
Ruff, M ;
Kannan, R ;
Cuniasse, P ;
Yiotakis, A ;
Dive, V ;
Rio, MC ;
Basset, P ;
Moras, D .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (02) :577-586
[26]   Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: Implications for drug design [J].
Gavuzzo, E ;
Pochetti, G ;
Mazza, F ;
Gallina, C ;
Gorini, B ;
D'Alessio, S ;
Pieper, M ;
Tschesche, H ;
Tucker, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (18) :3377-3385
[27]   THE NMR STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 [J].
GOOLEY, PR ;
OCONNELL, JF ;
MARCY, AI ;
CUCA, GC ;
SALOWE, SP ;
BUSH, BL ;
HERMES, JD ;
ESSER, CK ;
HAGMANN, WK ;
SPRINGER, JP ;
JOHNSON, BA .
NATURE STRUCTURAL BIOLOGY, 1994, 1 (02) :111-118
[28]  
GRAMS F, 1995, EUR J BIOCHEM, V228, P830, DOI 10.1111/j.1432-1033.1995.0830m.x
[29]   STRUCTURE DETERMINATION AND ANALYSIS OF HUMAN NEUTROPHIL COLLAGENASE COMPLEXED WITH A HYDROXAMATE INHIBITOR [J].
GRAMS, F ;
CRIMMIN, M ;
HINNES, L ;
HUXLEY, P ;
PIEPER, M ;
TSCHESCHE, H ;
BODE, W .
BIOCHEMISTRY, 1995, 34 (43) :14012-14020
[30]   Cooperativity, partially bound states, and enthalpy-entropy compensation [J].
Hunter, CA ;
Tomas, S .
CHEMISTRY & BIOLOGY, 2003, 10 (11) :1023-1032